Smart Immunomodulating Nanocomposites Enabling on-Demand Solid Tumor Treatment With Quasi-Real-Time Response...

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Cancer Research

Background:

• Cancer immunotherapies face challenges including limited efficacy in solid tumors, adverse effects, and high costs.
• Developing targeted delivery systems is crucial for improving cancer treatment outcomes.

Purpose of the Study:

• To develop a theranostic magnetic nanocomposite (mNC) system for on-demand delivery of small-molecule immunomodulating drugs (smIDs) to solid tumors.
• To enable externally triggered drug release and simultaneous MRI monitoring for precise cancer treatment.

Main Methods:

• Fabrication of a magnetic nanocomposite (mNC) system for drug delivery.
• Functionalization with a granzyme B (GzmB)-responsive fluorescent probe for immune activation assessment.
• In vitro and ex vivo validation using cancer models to evaluate drug delivery, immune response, and imaging capabilities.

Main Results:

• The mNC system demonstrated effective mobilization of innate and adaptive immune responses.
• Achieved approximately 60% tumor cell viability reduction, correlated with GzmB activity and increased cytokine release.
• Validated MRI for tumor accumulation and optical imaging for immune cell activation reporting.

Conclusions:

• The developed theranostic mNC platform offers precise spatio-temporal control of immunotherapy delivery.
• Combines noninvasive imaging and immune response monitoring for enhanced cancer treatment specificity and efficacy.
• Represents a promising strategy for overcoming current limitations in cancer immunotherapy.